Home › Stocks › PMVP › All Fund Holders
PMVP — PMV PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $44.45M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Viking Global Investors history | Q1 2022 | 1.08M | $22.40M | 0.10% | Reduce |
| Casdin Capital history | Q2 2022 | 300.00K | $4.28M | 0.36% | New |
| Wellington Management Group history | Q3 2023 | 542.88K | $3.33M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 2.17M | $2.71M | 0.00% | Hold |
| Two Sigma Investments history | Q2 2026 | 1.95M | $2.62M | 0.00% | Add |
| Alkeon Capital Management history | Q2 2025 | 2.34M | $2.48M | 0.00% | Hold |
| CPP Investments history | Q2 2022 | 113.50K | $1.62M | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 919.82K | $1.23M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 473.16K | $634.62K | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 321.61K | $430.96K | 0.00% | Reduce |
| Moore Capital Management history | Q4 2023 | 104.00K | $322.40K | 0.01% | Reduce |
| Bank of America Corp history | Q2 2026 | 240.11K | $321.75K | 0.00% | Hold |
| Balyasny Asset Management history | Q4 2022 | 34.15K | $297.08K | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2024 | 178.59K | $289.32K | 0.00% | Reduce |
| Prudential Financial history | Q2 2023 | 33.36K | $208.83K | 0.00% | New |
| BNY Mellon history | Q1 2024 | 117.10K | $199.07K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2024 | 118.92K | $192.65K | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 136.99K | $183.57K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 93.05K | $124.68K | 0.00% | Reduce |
| Manulife Financial history | Q3 2023 | 16.93K | $103.98K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 67.94K | $91.04K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q3 2025 | 55.72K | $78.00K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 47.31K | $63.39K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 41.68K | $55.86K | 0.00% | Reduce |
| Amundi US history | Q3 2024 | 26.18K | $38.88K | 0.00% | New |
| Point72 Asset Management history | Q1 2026 | 20.95K | $25.97K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 19.30K | $25.86K | 0.00% | Hold |
| Millennium Management history | Q2 2025 | 24.00K | $25.43K | 0.00% | Reduce |
| Principal Global Investors history | Q1 2024 | 14.18K | $24.11K | 0.00% | Reduce |
| Invesco Ltd history | Q1 2024 | 11.31K | $19.24K | 0.00% | Reduce |
| Wells Fargo & Co history | Q1 2025 | 10.00K | $10.90K | 0.00% | New |
| Legal & General Investment Management America history | Q1 2024 | 3.47K | $5.90K | 0.00% | Hold |
| Deutsche Bank AG history | Q1 2024 | 1.62K | $2.75K | 0.00% | Hold |
| UBS Group AG history | Q2 2026 | 361 | $484 | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q1 2025 | 315 | $343 | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 214 | $276 | 0.00% | New |
| T. Rowe Price Associates history | Q1 2025 | 33.60K | $37 | 0.00% | Hold |